UniProt ID | PRS8_HUMAN | |
---|---|---|
UniProt AC | P62195 | |
Protein Name | 26S proteasome regulatory subunit 8 | |
Gene Name | PSMC5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 406 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC5 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides.. | |
Protein Sequence | MALDGPEQMELEEGKAGSGLRQYYLSKIEELQLIVNDKSQNLRRLQAQRNELNAKVRLLREELQLLQEQGSYVGEVVRAMDKKKVLVKVHPEGKFVVDVDKNIDINDVTPNCRVALRNDSYTLHKILPNKVDPLVSLMMVEKVPDSTYEMIGGLDKQIKEIKEVIELPVKHPELFEALGIAQPKGVLLYGPPGTGKTLLARAVAHHTDCTFIRVSGSELVQKFIGEGARMVRELFVMAREHAPSIIFMDEIDSIGSSRLEGGSGGDSEVQRTMLELLNQLDGFEATKNIKVIMATNRIDILDSALLRPGRIDRKIEFPPPNEEARLDILKIHSRKMNLTRGINLRKIAELMPGASGAEVKGVCTEAGMYALRERRVHVTQEDFEMAVAKVMQKDSEKNMSIKKLWK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 (in isoform 2) | Acetylation | - | 8.24 | 22814378 | |
2 | Acetylation | ------MALDGPEQM ------CCCCCHHHC | 17.85 | 19413330 | |
9 | Sulfoxidation | ALDGPEQMELEEGKA CCCCHHHCCCCCCCC | 6.39 | 28465586 | |
15 | Ubiquitination | QMELEEGKAGSGLRQ HCCCCCCCCCCCHHH | 53.51 | 21906983 | |
15 | Acetylation | QMELEEGKAGSGLRQ HCCCCCCCCCCCHHH | 53.51 | 25953088 | |
21 | Methylation | GKAGSGLRQYYLSKI CCCCCCHHHHHHHHH | 26.44 | 115492879 | |
24 | Phosphorylation | GSGLRQYYLSKIEEL CCCHHHHHHHHHHHH | 9.00 | - | |
26 | Phosphorylation | GLRQYYLSKIEELQL CHHHHHHHHHHHHHH | 18.57 | - | |
27 | Ubiquitination | LRQYYLSKIEELQLI HHHHHHHHHHHHHHH | 52.09 | - | |
38 | Ubiquitination | LQLIVNDKSQNLRRL HHHHHCCCCHHHHHH | 49.06 | 21906983 | |
55 | Ubiquitination | QRNELNAKVRLLREE HHHHHHHHHHHHHHH | 27.15 | 21906983 | |
55 | Acetylation | QRNELNAKVRLLREE HHHHHHHHHHHHHHH | 27.15 | 25953088 | |
72 | Phosphorylation | LLQEQGSYVGEVVRA HHHHCCCCHHHHHHH | 21.21 | - | |
80 | Ubiquitination | VGEVVRAMDKKKVLV HHHHHHHCCCCCEEE | 5.63 | 21890473 | |
86 | Ubiquitination | AMDKKKVLVKVHPEG HCCCCCEEEEEECCC | 4.19 | 21890473 | |
88 | Ubiquitination | DKKKVLVKVHPEGKF CCCCEEEEEECCCCE | 30.57 | 21906983 | |
88 | Acetylation | DKKKVLVKVHPEGKF CCCCEEEEEECCCCE | 30.57 | 23236377 | |
94 | Acetylation | VKVHPEGKFVVDVDK EEEECCCCEEEEECC | 33.07 | 25953088 | |
94 | Ubiquitination | VKVHPEGKFVVDVDK EEEECCCCEEEEECC | 33.07 | 21906983 | |
101 | Ubiquitination | KFVVDVDKNIDINDV CEEEEECCCCCCCCC | 56.50 | - | |
101 | Acetylation | KFVVDVDKNIDINDV CEEEEECCCCCCCCC | 56.50 | 26051181 | |
109 | Phosphorylation | NIDINDVTPNCRVAL CCCCCCCCCCCEEEE | 16.20 | 20068231 | |
112 | Glutathionylation | INDVTPNCRVALRND CCCCCCCCEEEECCC | 3.79 | 22555962 | |
117 | Ubiquitination | PNCRVALRNDSYTLH CCCEEEECCCCEEHH | 34.86 | 21890473 | |
120 | Phosphorylation | RVALRNDSYTLHKIL EEEECCCCEEHHHHC | 24.46 | 23401153 | |
121 | Phosphorylation | VALRNDSYTLHKILP EEECCCCEEHHHHCC | 19.04 | 28796482 | |
121 | Nitration | VALRNDSYTLHKILP EEECCCCEEHHHHCC | 19.04 | - | |
122 | Phosphorylation | ALRNDSYTLHKILPN EECCCCEEHHHHCCC | 26.74 | 28796482 | |
122 | Ubiquitination | ALRNDSYTLHKILPN EECCCCEEHHHHCCC | 26.74 | 21890473 | |
125 | Ubiquitination | NDSYTLHKILPNKVD CCCEEHHHHCCCCCC | 49.39 | 21906983 | |
130 | Ubiquitination | LHKILPNKVDPLVSL HHHHCCCCCCCHHHH | 46.18 | 21906983 | |
136 | Phosphorylation | NKVDPLVSLMMVEKV CCCCCHHHHEEEEEC | 20.45 | 20068231 | |
142 | Ubiquitination | VSLMMVEKVPDSTYE HHHEEEEECCCCHHH | 47.89 | - | |
146 | Phosphorylation | MVEKVPDSTYEMIGG EEEECCCCHHHHCCC | 27.15 | 30622161 | |
147 | Phosphorylation | VEKVPDSTYEMIGGL EEECCCCHHHHCCCH | 30.77 | 30622161 | |
148 | Phosphorylation | EKVPDSTYEMIGGLD EECCCCHHHHCCCHH | 13.88 | 25147952 | |
150 | Sulfoxidation | VPDSTYEMIGGLDKQ CCCCHHHHCCCHHHH | 2.13 | 21406390 | |
156 | Ubiquitination | EMIGGLDKQIKEIKE HHCCCHHHHHHHHHH | 59.99 | 21906983 | |
162 | Ubiquitination | DKQIKEIKEVIELPV HHHHHHHHHHHCCCC | 47.20 | 21906983 | |
170 | Acetylation | EVIELPVKHPELFEA HHHCCCCCCHHHHHH | 52.05 | 21466224 | |
170 | Ubiquitination | EVIELPVKHPELFEA HHHCCCCCCHHHHHH | 52.05 | 21906983 | |
184 | Ubiquitination | ALGIAQPKGVLLYGP HHCCCCCCEEEEECC | 49.96 | 21906983 | |
188 | Ubiquitination | AQPKGVLLYGPPGTG CCCCEEEEECCCCCC | 4.28 | 21890473 | |
189 | Phosphorylation | QPKGVLLYGPPGTGK CCCEEEEECCCCCCH | 24.35 | 28152594 | |
194 | Phosphorylation | LLYGPPGTGKTLLAR EEECCCCCCHHHHHH | 41.08 | 28152594 | |
196 | Ubiquitination | YGPPGTGKTLLARAV ECCCCCCHHHHHHHH | 35.52 | 21906983 | |
196 | Acetylation | YGPPGTGKTLLARAV ECCCCCCHHHHHHHH | 35.52 | 25953088 | |
197 | Phosphorylation | GPPGTGKTLLARAVA CCCCCCHHHHHHHHH | 28.48 | 23186163 | |
214 | Acetylation | TDCTFIRVSGSELVQ CCCEEEECCHHHHHH | 6.94 | 19608861 | |
214 | Ubiquitination | TDCTFIRVSGSELVQ CCCEEEECCHHHHHH | 6.94 | 19608861 | |
214 | Ubiquitination | TDCTFIRVSGSELVQ CCCEEEECCHHHHHH | 6.94 | 21890473 | |
217 | Phosphorylation | TFIRVSGSELVQKFI EEEECCHHHHHHHHH | 21.91 | - | |
222 | Ubiquitination | SGSELVQKFIGEGAR CHHHHHHHHHHHHHH | 31.31 | 21906983 | |
222 | Acetylation | SGSELVQKFIGEGAR CHHHHHHHHHHHHHH | 31.31 | 19608861 | |
244 | Phosphorylation | MAREHAPSIIFMDEI HHHHHCCEEEEEECC | 29.15 | 20071362 | |
248 | Sulfoxidation | HAPSIIFMDEIDSIG HCCEEEEEECCCCCC | 2.96 | 30846556 | |
256 | Phosphorylation | DEIDSIGSSRLEGGS ECCCCCCCCCCCCCC | 15.60 | 20071362 | |
257 | Phosphorylation | EIDSIGSSRLEGGSG CCCCCCCCCCCCCCC | 35.35 | 20071362 | |
263 | Phosphorylation | SSRLEGGSGGDSEVQ CCCCCCCCCCCHHHH | 50.92 | 21712546 | |
267 | Phosphorylation | EGGSGGDSEVQRTML CCCCCCCHHHHHHHH | 42.83 | 25262027 | |
273 | Sulfoxidation | DSEVQRTMLELLNQL CHHHHHHHHHHHHHC | 2.74 | 28183972 | |
287 | Ubiquitination | LDGFEATKNIKVIMA CCCHHHCCCCEEEEE | 64.82 | 21906983 | |
290 | Ubiquitination | FEATKNIKVIMATNR HHHCCCCEEEEECCC | 34.79 | - | |
303 | Phosphorylation | NRIDILDSALLRPGR CCCCCCCHHHCCCCC | 19.85 | 20068231 | |
314 | Ubiquitination | RPGRIDRKIEFPPPN CCCCCCCCCCCCCCC | 42.72 | 21906983 | |
330 | Ubiquitination | EARLDILKIHSRKMN HHHHHHHHHHHHCCC | 38.41 | 21906983 | |
330 | Acetylation | EARLDILKIHSRKMN HHHHHHHHHHHHCCC | 38.41 | 25953088 | |
346 | Ubiquitination | TRGINLRKIAELMPG CCCCCHHHHHHHCCC | 49.81 | - | |
351 | Sulfoxidation | LRKIAELMPGASGAE HHHHHHHCCCCCCCE | 1.85 | 21406390 | |
360 | Ubiquitination | GASGAEVKGVCTEAG CCCCCEEEEEECHHH | 36.81 | - | |
363 | Glutathionylation | GAEVKGVCTEAGMYA CCEEEEEECHHHHHH | 3.76 | 22555962 | |
364 | Phosphorylation | AEVKGVCTEAGMYAL CEEEEEECHHHHHHH | 26.85 | - | |
368 | Sulfoxidation | GVCTEAGMYALRERR EEECHHHHHHHHHCC | 1.97 | 21406390 | |
369 | Phosphorylation | VCTEAGMYALRERRV EECHHHHHHHHHCCC | 11.10 | 23917254 | |
379 | Phosphorylation | RERRVHVTQEDFEMA HHCCCCCCHHHHHHH | 16.03 | 20068231 | |
385 | Sulfoxidation | VTQEDFEMAVAKVMQ CCHHHHHHHHHHHHH | 3.52 | 21406390 | |
389 | Ubiquitination | DFEMAVAKVMQKDSE HHHHHHHHHHHHHHH | 31.47 | 21906983 | |
397 | Ubiquitination | VMQKDSEKNMSIKKL HHHHHHHHCCCCHHH | 63.00 | 21906983 | |
397 | Acetylation | VMQKDSEKNMSIKKL HHHHHHHHCCCCHHH | 63.00 | 25953088 | |
402 | Ubiquitination | SEKNMSIKKLWK--- HHHCCCCHHHCC--- | 34.21 | - | |
403 | Ubiquitination | EKNMSIKKLWK---- HHCCCCHHHCC---- | 58.89 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
120 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRS8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRS8_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Mass spectrometric characterization of the affinity-purified human26S proteasome complex."; Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.; Biochemistry 46:3553-3565(2007). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-222, AND MASS SPECTROMETRY. |